ST. PAUL VENTURE CAPITAL
Founded in 1988, St. Paul Venture Capital is one of the largest early-stage venture capital funds in the United States with $3.0 billion in committed capital and offices in Minneapolis, Boston and Silicon Valley. With The St. Paul Companies as a single limited partner, the firm invests primarily in the areas of Communications, Software and Services and Healthcare. For more information, visit the firm's website at http://www.spvc.com
ST. PAUL VENTURE CAPITAL
Social Links:
Industry:
Venture Capital
Founded:
1988-01-01
Status:
Closed
Contact:
(952) 995-7474
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Similar Organizations
Ericsson Ventures
Ericsson Ventures is a venture capital and private equity firm that invests in innovative companies.
Goat Capital
Goat Capital is a venture capital firm that invests in early-stage companies.
Golden Capital Network
Golden Capital Network is a private equity firm that invests in early-stage companies.
Magarac Venture Partners
Magarac Venture Partners is a venture firm that invests in early-stage companies.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-04-08 | EBR Systems | St. Paul Venture Capital investment in Venture Round - EBR Systems | 20 M USD |
2014-07-01 | EBR Systems | St. Paul Venture Capital investment in Venture Round - EBR Systems | 18.7 M USD |
2007-05-09 | SPS Commerce | St. Paul Venture Capital investment in Venture Round - SPS Commerce | 7.5 M USD |
2007-03-05 | Disc Dynamics | St. Paul Venture Capital investment in Series F - Disc Dynamics | 26.31 M USD |
2005-10-01 | EBR Systems | St. Paul Venture Capital investment in Series B - EBR Systems | 21 M USD |
2005-01-06 | Dexcom | St. Paul Venture Capital investment in Series D - Dexcom | 22.5 M USD |
2004-12-21 | Myocor | St. Paul Venture Capital investment in Series D - Myocor | 24 M USD |
2004-08-05 | Avera Pharmaceutical | St. Paul Venture Capital investment in Series C - Avera Pharmaceutical | 48 M USD |
2004-07-14 | SkinMedica | St. Paul Venture Capital investment in Series D - SkinMedica | 30 M USD |
2004-06-25 | Emphasys Medical | St. Paul Venture Capital investment in Series D - Emphasys Medical | 27.5 M USD |